Light-activated Drug Could Reduce Side Effects of Diabetes Medication

News   Oct 16, 2014

 
Light-activated Drug Could Reduce Side Effects of Diabetes Medication
 
 
 

RELATED ARTICLES

Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's Disease

News

Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.

READ MORE

Obese and Anorexic Women Have Low Levels of ‘Feel Good’ Neurosteroid

News

Researchers have found that women at opposite extremes of the weight spectrum have low levels of the neuroactive steroid allopregnanolone, a metabolite of the hormone progesterone. Gas chromatography and mass spectrometry were used to pick up extremely small levels of these chemicals in blood serum, saliva and brain tissue.

READ MORE

Fat Cells May Inactivate Chemotherapeutic Drug

News

A recent study showed that adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE